
A real-world “symptom-active / structure-stable” SpA/PsA overlap case across 5 years of serial X-rays + DXA—showing how a validator-governed, deterministic workflow can turn longitudinal imaging into reproducible, endpoint-relevant signals without exposing proprietary algorithms. When symptoms stay active for years, how do you prove “no new damage” — reproducibly, across timepoints and sites? This de-identified real-world case illustrates a high-friction phenotype in spondyloarthritis/psoriatic disease: persistent clinical activity with minimal structural drift over a five-year horizon. Despite multiple advanced-therapy exposures across distinct mechanisms (including IL-17A/F inhibition with bimekizumab) and recurrent symptomatic flares, serial radiography (2020–2025) shows no progression to radiographic sacroiliitis, syndesmophyte formation, or hip involvement. What this record contributes (beyond a typical case report): Endpoint relevance: a “discordance anchor” demonstrating why symptom-based endpoints can move while conventional radiographic structural endpoints remain flat—useful for mixed endpoint strategies and trial design. Cohort stratification: a concrete example of a low-progression, symptom-dominant subgroup that can reduce noise in registries, external/synthetic controls, and subgroup analyses. Cross-modal coherence: DXA (Nov 2025) is normal with high XR–DXA concordance, supporting a coherent “structure-stable” interpretation rather than measurement artifacts. What’s inside: Longitudinal, multi-region imaging spanning cervical/thoracic/lumbar spine + sacroiliac joints/pelvis + hips, with DXA correlation at the index timepoint (Nov 2025). A validator-governed, deterministic radiographic workflow emphasizing projection and completeness checks, producing reproducible longitudinal outputs with audit-ready lineage per timepoint (described at a high level; no proprietary implementation details disclosed). Research-facing composite stability descriptors presented at an implementation-opaque level (designed for harmonization without exposing internal algorithms). Collaboration note: Beyond the representative figures in this vignette, additional de-identified full-resolution images and structured summary tables may be available to qualified collaborators under controlled-access terms. Use and positioning: Educational/research communication only; not medical advice. No regulatory, diagnostic accuracy, or performance claims
psoriatic arthritis, DXA, non-radiographic axial SpA, musculoskeletal imaging, validator-governed analytics, clinical trials, DEXA, research, validator, radiographic stability, rheumatology, longitudinal cohort, spondyloarthritis, artificial intelligence, longitudinal radiography, radiology, rheumaview, ankylosing spondylitis, Bone mineral density, biologics, symptom–structure discordance, bimekizumab, psoriatic spondylitis
psoriatic arthritis, DXA, non-radiographic axial SpA, musculoskeletal imaging, validator-governed analytics, clinical trials, DEXA, research, validator, radiographic stability, rheumatology, longitudinal cohort, spondyloarthritis, artificial intelligence, longitudinal radiography, radiology, rheumaview, ankylosing spondylitis, Bone mineral density, biologics, symptom–structure discordance, bimekizumab, psoriatic spondylitis
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
